Key Record Dates Identifier: NCT04181827
Brief Title: A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma (CARTITUDE-4)

First Submitted : November 27, 2019
First Submitted that Met QC Criteria : November 27, 2019
First Posted : December 2, 2019

Last Update Submitted that Met QC Criteria : June 24, 2021
Last Update Posted : June 25, 2021